Based on FY16 second quarter, formula accounted for $ 130...

Based on FY16 second quarter, formula accounted for $ 130 million revenue on 55% of
company earnings. There was a 40% growth between June and August of formula alone,
with a revenue target for FY17 of $182 million for first quarter, and $220 million for second
quarter. This makes a total of $ 402 million. Adult milk powder revenue is approx $65 million
for FY17.
Fresh milk sales accounted for $48.5 million first quarter, and based on 5% growth quarter
on quarter, the outlook is $110 million for FY17.
UK and USA revenue first quarter FY16 is $8.5 million based on minimal distribution. UK
is now profitable, and USA is now officially launched. Revenue is estimated to be $40 million
for both countries as a combined total.
New Zealand comes online in January. Revenue is estimated to be $10 million- not sure where
daigou sales will sit in this figure.
China revenue for FY16 estimated to be $2.8 million. This is based on contacts in China,
clinical studies, and growing distribution via Netease. FY17 is estimated to be around $20-30
million in revenue. Total revenue target for FY17 =$657 million. However, the estimated
range will be between $650-700 million with EBITA of $100-110 million.

GLTAH.